Evidence map›Paper›PMID 23659599›Full record

ArticleNeuropathology and applied neurobiology2014

Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.

G Y López, G A Grant, H E Fuchs, L G Leithe, S Gururangan, D D Bigner, H Yan, R E McLendon, Y He

Open access · greenAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropathology and applied neurobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

G Y LópezThe Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA; The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA; Department of Pathology, Duke University Medical Center, Durham, NC, USA.
G A Grant
H E Fuchs
L G Leithe
S Gururangan
D D Bigner
H Yan
R E McLendon
Y He
Duke University Hospital · USDuke Medical Center · USPediatric Brain Tumor Foundation · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
The Role of OTX2 in Molecular Pathogenesis of MedulloblastomaR01CA118822 · NCI · DUKE UNIVERSITY · PI YAN, HAI · 2006 to 2010
$1.2M
Modulation of the Blood-Tumor Barrier Through Targeted Suppression of Claudin 5K08NS075144 · NINDS · STANFORD UNIVERSITY · PI GRANT, GERALD ARTHUR · 2011 to 2015
$641k
NCI NIH HHS R01 CA118822NCI NIH HHS R01-CA-118822-01NIGMS NIH HHS T32 GM007171NINDS NIH HHS K08 NS075144
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cerebellar NeoplasmsChildChild, PreschoolDNA-Binding ProteinsFemaleHumansMaleMedulloblastomaMutationNeoplasm ProteinsDNA-Binding ProteinsKMT2C protein, humanKMT2D protein, humanNeoplasm Proteins

Identifiers

PMID23659599
PMCPMC4076194
OpenAlexW1803785621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.